Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Intellia Therapeutics (NTLA) Asset Utilization Ratio (2016 - 2025)

Intellia Therapeutics (NTLA) has disclosed Asset Utilization Ratio for 10 consecutive years, with 0.08 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio rose 56.41% to 0.08 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.08 through Dec 2025, up 56.41% year-over-year, with the annual reading at 0.07 for FY2025, 43.31% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.08 at Intellia Therapeutics, up from 0.06 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.08 in Q4 2025, with the low at 0.02 in Q3 2021.
  • Average Asset Utilization Ratio over 5 years is 0.05, with a median of 0.05 recorded in 2023.
  • The sharpest move saw Asset Utilization Ratio plummeted 82.71% in 2021, then skyrocketed 251.49% in 2022.
  • Over 5 years, Asset Utilization Ratio stood at 0.04 in 2021, then surged by 53.91% to 0.06 in 2022, then plummeted by 49.91% to 0.03 in 2023, then soared by 63.08% to 0.05 in 2024, then soared by 56.41% to 0.08 in 2025.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.08, 0.06, and 0.06 for Q4 2025, Q3 2025, and Q2 2025 respectively.